Stock Events

Stock Events

Corbus Pharmaceuticals (3371.F) Q2 2024 Earnings

7MayConfirmed

Q4 2023

Q2 2024

-1.97

-1.57

-1.17

-0.77

Details

Expected EPS

-1.0137

Actual EPS

-0.7719

Surprise EPS

0.24

Surprise Percent

+23.85%

Description

Corbus Pharmaceuticals (3371.F) has reported earnings of -0.7719 per share for Q2 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.